Drugs Made In America Acquisition Corp. (DMAAU) EPS (Basic) (2025)

Drugs Made In America Acquisition's (DMAAU) quarterly EPS (Basic) came in at -$0.09 in Q4 2025, down 234.35% on a QoQ basis from $0.07 in Q3 2025.

Drugs Made In America Acquisition Corp. (DMAAU) EPS (Basic) (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAAU) has 1 years of EPS (Basic) data on file, last reported at -$0.09 in Q4 2025.

Quarterly EPS (Basic) changed N/A year-over-year to -$0.09 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.1 (changed N/A YoY) and the FY2025 annual result came in at $0.09, up 387.72% from the prior year.
EPS (Basic) declined to -$0.09 in Q4 2025, from $0.07 in the prior quarter.
In the past five years, EPS (Basic) ranged from a high of $0.07 in Q2 2025 to a low of -$0.09 in Q4 2025.

Download Data